NATDAC DACLATASVIR TABLETS

Get a Price/Quote

NATDAC DACLATASVIR TABLETS Specification

Dosage Form
Tablet

Pacakaging (Quantity Per Box)
28 Tablets

Salt Composition
Daclatasvir Dihydrochloride

Origin of Medicine
India

Indication
Chronic Hepatitis C infection

Drug Type
Other Types

Ingredients
sofosbuvir

Physical Form
Tablets

Function
Antiviral medication for Hepatitis C

Recommended For
Adults with chronic Hepatitis C infection

Dosage
2.5 mg

Dosage Guidelines
Take as prescribed by the healthcare provider

Suitable For
Adults

Quantity
28 Tablets per pack

Storage Instructions
Store below 30C, protect from moisture and light

NATDAC DACLATASVIR TABLETS Trade Information

Packaging Details
pack of 28 tablets

Main Domestic Market
All India

Certifications
natdac tablets content sofosbuvir form tablets packing pack of 28 tablets manufacturer by natco

About NATDAC DACLATASVIR TABLETS

Vir

Specification:-

Product name : Natdac
Content: sofosbuvir dhydrochloride
Form :Tablets
Strength: 60 mg
Packing: Pack of 28 tablets
Manufactured by : Natco

Natdac 60mg

Natdac Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug.............

Powerful Antiviral Action for Hepatitis C

NATDAC DACLATASVIR TABLETS are formulated to combat chronic Hepatitis C infection in adults. With Daclatasvir Dihydrochloride as their primary component, these tablets disrupt virus replication, helping to control and reduce the viral load. Used in combination with sofosbuvir as prescribed, they form an integral part of Hepatitis C treatment protocols.

Proper Usage and Dosage Guidelines

Patients should take the tablets strictly according to their healthcare providers prescription. Swallow the tablets whole with water, preferably at the same time each day, to maintain consistent levels in the bloodstream. Regular intake as directed is crucial for treatment efficacy. Any adjustment or missed dose must be discussed with the prescribing doctor.

Safe Storage and Handling

To preserve efficacy, NATDAC DACLATASVIR TABLETS must be stored below 30C, protected from moisture and direct light. Each pack contains 28 tablets for convenient dosing. Proper storage ensures the medicine remains potent for up to 24 months following manufacture.

FAQs of NATDAC DACLATASVIR TABLETS:

Q: How should I take NATDAC DACLATASVIR TABLETS?

A: Take NATDAC DACLATASVIR TABLETS orally as prescribed by your healthcare provider. Swallow the tablet whole, often once daily, and try to take it at the same time each day for the best results. Do not adjust your dosage without consulting your doctor.

Q: What is the main benefit of using NATDAC DACLATASVIR TABLETS?

A: The primary benefit of NATDAC DACLATASVIR TABLETS is their ability to help treat chronic Hepatitis C infection in adults, often in combination with sofosbuvir. By inhibiting the replication of the hepatitis C virus, they effectively help reduce the viral load and support recovery.

Q: When should this medication be avoided?

A: NATDAC DACLATASVIR TABLETS are not recommended during pregnancy or breastfeeding unless your doctor specifically prescribes them. Always inform your healthcare provider about your medical history before starting this medication.

Q: Where should I store NATDAC DACLATASVIR TABLETS?

A: Keep the tablets stored below 30C in a dry place, away from moisture and direct light. Proper storage maintains the medications effectiveness throughout its 24-month shelf life.

Q: What should I do if I miss a dose?

A: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed one and resume your regular schedule. Do not take two doses at once. Consult your healthcare provider if you miss multiple doses.

Q: Who can prescribe NATDAC DACLATASVIR TABLETS?

A: Only authorized healthcare professionals can prescribe NATDAC DACLATASVIR TABLETS, as they require a valid prescription and careful patient monitoring during treatment.

Q: What precautions should I follow while using this medication?

A: Follow your healthcare providers directions closely, and do not share the medication with others. Regular monitoring and follow-ups may be required. Avoid starting this medication if you are pregnant or breastfeeding unless advised by your doctor.

Tell us about your requirement